Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab REPLY

被引：0
|
作者：
Tan, Chen S. [1 ]
Kinkel, R. Philip [1 ]
Koralnik, Igor J. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2489 / 2490
页数：2
相关论文
共 50 条
  • [41] JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
    Major, Eugene O.
    Frohman, Elliot
    Douek, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2240 - 2241
  • [42] REACTIVATION OF BK VIRUS IN PATIENTS WITH MULTIPLE SCLEROSIS ON NATALIZUMAB THERAPY
    Lonergan, R.
    De Gascun, C. F.
    Carr, M. J.
    Costelloe, L.
    Fletcher, J.
    Waters, A.
    Coughlan, S.
    Duggan, M.
    Doyle, K.
    Jordan, S.
    Hall, W. W.
    Hutchinson, M.
    Tubridy, N.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [43] Evaluation of the incidence of anti-JC virus antibodies in a cohort of natalizumab-treated patients.
    Pepio, A.
    Taylor, L.
    Jaros, M.
    Mocci, S.
    Taylor, J.
    Yednock, T.
    Plavina, T.
    Gorelik, L.
    Goelz, S.
    Subramanyam, M.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S36 - S36
  • [44] Lack of correlation between JC Virus urinary shedding and seropositivity in Multiple Sclerosis patients treated with natalizumab
    Delbue, Serena
    Elia, Francesca
    Carloni, Camilla
    Pecchenini, Valentina
    Carluccio, Silvia
    Franciotta, Diego
    Gastaldi, Matteo
    Ferrante, Pasquale
    JOURNAL OF NEUROVIROLOGY, 2013, 19 : S23 - S24
  • [45] Cellular response to JC virus: a longitudinal study in a population of natalizumab-treated multiple sclerosis patients
    Masera, S.
    Costa, C.
    Dematteis, F.
    Superti, G.
    Romagnolo, A.
    Mattioda, A.
    Pinessi, L.
    Lopiano, L.
    Cavallo, R.
    Cavalla, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 232 - 233
  • [46] qPCR versus two-step ELISA to detect JC virus in natalizumab-treated patients
    Dominguez-Mozo, M. I.
    Garcia-Montojo, M.
    De las Heras, V.
    Garcia-Martinez, M. A.
    Arias-Leal, A.
    Casanova, I.
    Arroyo, R.
    Alvarez-Lafuente, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 141 - 142
  • [47] Therapeutic Decision after JC Virus Testing in a Cohort of Patient Treated with Natalizumab
    Ongagna, Jean-Claude
    Fleury, Marie-Celine
    Collongues, Nicolas
    Blanc, Frederic
    de Seze, Jerome
    NEUROLOGY, 2013, 80
  • [48] JC virus detection in the cerebrospinal fluid of a natalizumab-treated patient with headache
    Riley, C.
    Bailey, M.
    Bennick, J.
    O'Connor, K.
    Hafler, D.
    Pelletier, D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S231 - S232
  • [49] More on JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
    Subramanyam, Meena
    Belachew, Shibeshih
    Compton, Teresa
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1279 - 1280
  • [50] Prevalence of anti-JC virus antibodies in a cohort of 1'200 natalizumab-treated MS patients
    Radji, F.
    Outteryck, O.
    Zephir, H.
    Ongagna, J. C.
    Brochet, B.
    Ouallet, J. C.
    Rumbach, L.
    Lebrun-Frenay, C.
    Debouverie, M.
    Pittion, S.
    Laplaud, D.
    Wiertlewski, S.
    Cabre, P.
    Confavreux, C.
    Vukusic, S.
    Pelletier, J.
    Audouin, B.
    Defer, G.
    Derache, N.
    Camu, W.
    Thouvenot, E.
    Tourbah, A.
    Labauge, P.
    Moreau, T.
    Fromont, A.
    Castelnovo, G.
    Clavelou, P.
    Casez, O.
    Hautecoeur, P.
    Papeix, C.
    Couturier, N.
    Viala, F.
    Liblau, R.
    Clanet, M.
    De Seze, J.
    Vermersch, P.
    Brassat, D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S216 - S216
12345